Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of repeated intra-articular SI-613 injections in osteoarthritis
jRCT2080223799Phase 3Completed
- Sponsor
- Seikagaku Corporation
- Start
- Feb 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of diclofenac etalhyaluronate in osteoarthritis (OA), sponsored by Seikagaku Corporation. Started Feb 2018; status: completed.
02
Drugs
diclofenac etalhyaluronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2080223799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223799.